Confirmatory evidence was obtained by showing miR-21, miR-221, and miR-222 induction was blocked by pre-incubating colon cancer cells with selective muscarinic, PKC, and p38 MAP kinase inhibitors. Here, PRRT2 is linked to malignant colon neoplasm.